What it's for (Indications)
- Zolpidem is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
- It is intended for use in patients experiencing transient or short-term insomnia, where the primary complaint is trouble falling asleep.
- The decision to use zolpidem should be based on a thorough clinical assessment, ruling out underlying medical or psychiatric conditions that may contribute to insomnia.
- Treatment duration should generally be limited, and re-evaluation is necessary if insomnia persists beyond 7-10 days, as persistent insomnia may indicate a primary medical or psychiatric illness that requires specific treatment.
- It is not recommended for chronic use without periodic re-assessment of patient need and risk.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For most adult patients, the recommended initial dose of zolpidem immediate-release tablets is 5 mg taken orally once daily immediately before bedtime. The dose may be increased to 10 mg if the 5 mg dose is not effective. The maximum recommended dose is 10 mg once daily. For elderly or debilitated patients, and those with hepatic impairment, the recommended initial dose is 5 mg once daily immediately before bedtime. Dosage adjustments may be necessary based on individual patient response and tolerability, always striving for the lowest effective dose. Zolpidem should be taken as a single dose and not re-administered during the same night. It should be taken on an empty stomach, as administration with or immediately after a meal can delay its onset of action. Patients should be advised to allow at least 7 to 8 hours for sleep after taking zolpidem to minimize next-day impairment. |
Safety & Warnings
Common Side Effects
- Common side effects associated with zolpidem include drowsiness, dizziness, headache, nausea, diarrhea, fatigue, and dry mouth.
- More serious adverse reactions, though less common, can occur.
- These include complex sleep behaviors, such as sleep-driving, sleep-eating, making phone calls, or engaging in other activities while not fully awake and having no memory of the event.
- Other serious effects include severe allergic reactions (anaphylaxis and angioedema involving swelling of the face, tongue, and throat, which can be fatal), worsening of depression or emergence of suicidal thoughts, respiratory depression, and paradoxical reactions (e.
- g.
- , agitation, hallucinations, aggression).
- There is also a risk of anterograde amnesia, particularly if insufficient sleep time is allowed after administration.
- Abrupt discontinuation, especially after prolonged use, can lead to withdrawal symptoms including rebound insomnia, tremor, abdominal cramps, vomiting, sweating, and seizures.
Serious Warnings
- Black Box Warning: Zolpidem can cause serious and potentially fatal complex sleep behaviors. These include 'sleep-driving' (driving while not fully awake after ingesting a sedative-hypnotic, with no memory of the event), making and eating food, making phone calls, engaging in sexual activity, or walking while not fully awake. These behaviors can occur in patients who have not previously experienced them and at recommended dosages. The risk of these behaviors may be increased by higher doses, concomitant use of alcohol or other central nervous system depressants, or a history of sleep disorders. Patients should be explicitly warned about these potential risks and instructed to discontinue zolpidem immediately if they experience any such complex sleep behavior. Serious injuries, including death, have been reported in association with these complex sleep behaviors. Healthcare providers should assess for underlying sleep disorders or other medical conditions contributing to insomnia before initiating treatment and counsel patients thoroughly on these risks.
- Patients using zolpidem are at risk for serious and potentially fatal complex sleep behaviors, including sleep-driving, making and eating food, making phone calls, or engaging in sexual activity while not fully awake, with no memory of the event.
- These behaviors can occur at recommended dosages and may lead to serious injuries or death.
- If a patient experiences any complex sleep behavior, zolpidem should be discontinued immediately.
- Zolpidem is a central nervous system (CNS) depressant and can impair alertness and motor coordination, potentially affecting driving and operating machinery the day following administration, even at recommended doses.
- The risk of next-day impairment is increased with higher doses, concomitant use of other CNS depressants or alcohol, and insufficient sleep duration (less than 7-8 hours).
- It should be used with caution in patients with compromised respiratory function, including those with sleep apnea or chronic obstructive pulmonary disease, due to the risk of respiratory depression.
- Zolpidem carries a risk of physical and psychological dependence, especially with prolonged use.
- Abrupt discontinuation can lead to withdrawal symptoms.
- It can also exacerbate underlying depression and increase the risk of suicidal ideation.
- Elderly patients are particularly susceptible to adverse effects, including falls and cognitive impairment.
- Use in patients with severe hepatic impairment should be avoided or doses significantly reduced due to impaired drug clearance.
How it Works (Mechanism of Action)
Zolpidem is a non-benzodiazepine hypnotic agent of the imidazopyridine class, structurally distinct from benzodiazepines. Its primary mechanism of action involves selective binding to the benzodiazepine omega-1 (ω1) receptor subtype of the gamma-aminobutyric acid (GABA)-A receptor complex, particularly those containing the α1 subunit. This selective binding enhances the inhibitory effects of GABA, the major inhibitory neurotransmitter in the brain, by increasing chloride ion influx through the GABA-gated chloride channel. The resulting hyperpolarization of neuronal membranes decreases neuronal excitability, leading to central nervous system depression. This targeted action on the α1 subunit is thought to be responsible for its potent hypnotic effects with minimal anxiolytic, myorelaxant, or anticonvulsant properties compared to less selective benzodiazepines, thereby promoting sleep initiation and maintenance.